[1]Li R,Zhang Q,Yang D,et al.Prevalence of polycysticovary syndrome in women in China:a large community-based study[J].Hum Reprod,2013,28(9):2562-2569.
[2]Moran LJ,Misso ML,Wild RA,et al.Impaired glucose tolerance,type 2 diabetes and metabolic syndrome in polycystic ovary syndrome:a systematic review and meta-analysis[J].Hum Reprod Update,2010,16(4):347-363.
[3]徐碧红,张 凤.肥胖与非肥胖多囊卵巢综合征患者内分泌激素对比研究[J].华南国防医学杂志,2011,25(5):446-447.
[4]Boomsma CM,Eijkemans MJ,Hughes EG,et al.A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome[J].Hum Reprod Update,2006,12(6):673-683.
[5]Haoula Z,Salman M,Atiomo W.Evaluating the association between endometrial cancer and polycystic ovary syndrome[J].Hum Reprod,2012,27(5):1327-1331.
[6]Rizzo M,Berneis K,Spinas G,et al.Long-term consequences of polycystic ovary syndrome on cardiovascular risk[J].Fertil Steril,2009,91(4 Suppl):1563-1567.
[7]Rotterdam.ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS)[J].Fertil Steril,2004,81(1):19-25.
[8]吴静静,刘锦霞,吴元赭,等.观察二甲双胍和螺内酯对多囊卵巢综合征患ghrelin的影响[J].东南国防医药,2009,11(4):289-292.
[9]罗助荣,林 毅,张克己,等.福建地区汉族人群骨保护素基因rs2073617T/C多态性与急性冠脉综合征病变程度的关系[J].东南国防医药,2011,13(5):385-388.
[10]Grigorova M,Punab M,Ausmees K,et al.FSHΒ promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men[J].Hum Reprod,2008,23(9):2160-2166.
[11]Schüring AN,Busch AS,Bogdanova N,et al.Effects of the FSH-β-subunit promoter polymorphism 211G→T on the hypothalamic-pituitary-ovarian axis in normally cycling women indicate a gender-specific regulation of gonadotropin secretion[J].J Clin Endocrinol Metab,2013,98(1):E82-E86.
[12]La Marca A,Papaleo E,Alviggi C,et al.The combination of genetic variants of the FSHΒ and FSHR genes affects serum FSH in women of reproductive age[J].Hum Reprod det,2013,28(5):1369-1374.
[13]Valkenburg O,Uitterlinden AG,Piersma D,et al.Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome[J].Hum Reprod,2009,24(8):2014-2022.
[14]谢 幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:19.
[1]吴静静,刘锦霞,吴元赭,等.观察二甲双胍和螺内酯对多囊卵巢
综合征患者ghrelin的影响[J].医学研究与战创伤救治(原医学研究生学报),2009,11(04):289.
WU Jing-jing,LIU Jin-xia,WU Yuan-zhe,et al.Studies on effects of Metformin and Spironolactone on plasma ghrelin in polycystic ovary syndrome[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(03):289.
[2]王小红,王志君,缪 铃,等.维生素D联合二甲双胍对多囊卵巢综合征患者排卵及子宫内膜容受性的影响研究[J].医学研究与战创伤救治(原医学研究生学报),2015,17(02):142.[doi:10.3969/j.issn.1672-271X.2015.02.009]
WANG Xiao-hong,WANG Zhi-jun,MIAO Ling,et al.Effect of vitamin D in combination with metformin in treatment of patients with PCOS ovulation and the receptivity of endometrium[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(03):142.[doi:10.3969/j.issn.1672-271X.2015.02.009]
[3]高梦颖 综述,黄惠娟 审校.影响多囊卵巢综合征骨密度改变的因素分析[J].医学研究与战创伤救治(原医学研究生学报),2016,18(04):405.[doi:10.3969/j.issn.1672-271X.2016.04.021]
[4]赖雪梅,黄金园,张海燕,等.个体化营养支持联合药物治疗多囊卵巢综合征的研究[J].医学研究与战创伤救治(原医学研究生学报),2021,23(01):32.[doi:10.3969/j.issn.1672-271X.2021.01.001]
LAI Xue-mei,HUANG Jin-yuan,ZHANG Hai-yan,et al.Effect of individualized nutritional support combined with drug therapy on polycystic ovary syndrome[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(03):32.[doi:10.3969/j.issn.1672-271X.2021.01.001]
[5]任洁,秦洁.Asprosin在性腺发育及其功能调节中的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2023,25(2):173.[doi:10.3969/j.issn.1672-271X.2023.02.013]
REN Jie,QIN Jie.Research progress of Asprosin in gonadal development and its function regulation[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2023,25(03):173.[doi:10.3969/j.issn.1672-271X.2023.02.013]